Article Text
Paper
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterized by quantitative DNA methylation analysis and prospective cohort studies
Statistics from Altmetric.com
This is a PDF-only article. The first page of the PDF of this article appears above.
Supplementary materials
Conflict of Interest: PWL is shareholder and Scientific Advisory Board Member of Epigenomics, AG, which has a commercial interest in the development of DNA methylation markers for disease detection and diagnosis. None of the work described in this manuscript was supported by Epigenomics, AG.